Bridget Brunner, MD
Obstetrics & Gynecology · Jasper, ALNPI 1427272129
Payments from drug & device makers
Across 158 payments — averaging $29.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$2K
- AbbVie$347
- Astellas Pharma US Inc$293
- Sumitomo Pharma America, Inc.$286
- Takeda Pharmaceuticals U.S.A., Inc.$197
- Ardelyx, Inc.$160
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,63656%
- Education$722%
- Other$1,98042%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 1 | $1,980 |
| AbbVie | 24 | $347 |
| Astellas Pharma US Inc | 17 | $293 |
| Sumitomo Pharma America, Inc. | 15 | $286 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $197 |
| Ardelyx, Inc. | 7 | $160 |
| Boston Scientific | 4 | $156 |
| Shield Therapeutics Inc | 8 | $138 |
| Duchesnay USA Incorporated | 14 | $127 |
| Johnson & Johnson | 4 | $101 |
| Novo Nordisk | 6 | $100 |
| Mayne Pharma Commercial LLC | 11 | $90 |
| Therapeuticsmd, Inc. | 5 | $64 |
| Exeltis, USA Inc. | 3 | $60 |
| Aspira Women's Health Inc | 1 | $53 |
| Amgen | 3 | $46 |
| Urovant Sciences Inc | 2 | $43 |
| Radius Health, Inc. | 2 | $42 |
| Hologic Sales And Service, LLC | 2 | $37 |
| AMAG Pharmaceuticals, Inc. | 2 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Intuitive Surgical | 1 | $35 |
| Evofem Biosciences, Inc. | 2 | $35 |
| Sage Therapeutics, LLC | 2 | $34 |
| Pfizer | 2 | $34 |
| Lilly USA, LLC | 2 | $31 |
| Bayer | 1 | $26 |
| Covidien LP | 1 | $23 |
| Baxter Healthcare | 1 | $21 |
| Axonics, Inc. | 1 | $20 |
| Scynexis, Inc. | 1 | $19 |
| Myovant Sciences Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$1,980
- Solyx SIS System$101
How this compares
$4,687 in reported general payments places this provider in the 85th percentile of 537 obstetrics & gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 39 | $27,129 |
| Estradiol | 236 | $13,046 |
| MyrbetriqMirabegron | 14 | $6,229 |
| PremarinEstrogens, Conjugated | 30 | $5,833 |
| OsphenaOspemifene | 13 | $3,096 |
| Risedronate Sodium DrRisedronate Sodium | 12 | $1,412 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 20 | $1,042 |
| ValacyclovirValacyclovir Hcl | 18 | $889 |
| Raloxifene Hcl | 12 | $576 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 13 | $511 |
| Clobetasol Propionate | 12 | $372 |
| Larin 24 FeNorethindrone-E.Estradiol-Iron | 11 | $290 |
| Medroxyprogesterone Acetate | 27 | $260 |
| Triamcinolone Acetonide | 30 | $175 |
| Fluconazole | 30 | $112 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $286 | $27,12939 claims |
| Astellas Pharma US IncMyrbetriq | $293 | $6,22914 claims |
| PfizerPremarin | $34 | $5,83330 claims |
| Duchesnay USA IncorporatedOsphena | $127 | $3,09613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 537 obstetrics & gynecology providers in Alabama.
Other obstetrics & gynecology in Jasper
- Guy MiddletonDothan$5.6M
- Charles SharpBirmingham$2.8M
- John WidemanCullman$2.3M
- Charles RogersMobile$1.8M
- Ronald OrsoBirmingham$1.6M
- Amy McCoyMobile$1.2M
- Theodore CatranisMobile$994K
- Theodore TsaltasBirmingham$853K
- Janeen ArbuckleBirmingham$601K
- Phillip MadoniaMobile$574K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.